Center for Imaging of Neurodegenerative Disease, San Francisco, CA, USA.
Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):19-27. doi: 10.1097/WAD.0b013e3181b4f736.
We compared the predictive value of cerebral perfusion as measured by arterial-spin labeling magnetic resonance imaging (ASL-MRI) with MRI-derived hippocampal volume for determining future cognitive and functional decline and subsequent conversion from mild cognitive impairment to dementia. Forty-eight mild cognitive impairment subjects received structural and ASL-MRI scans at baseline and clinical and neuropsychologic assessments annually. Thirteen subjects became demented during the period of longitudinal observation (2.7+/-1.0 y). Cox regression analyses suggest that baseline hippocampal volume [relative risk (RR)=0.99, P=0.004], baseline right inferior parietal (RR=0.64, P=0.01) and right middle frontal (RR=0.73, P=0.01) perfusion were associated with conversion to dementia. Results from linear mixed effects modeling suggest that baseline perfusion from the right precuneus predicted subsequent declines in Clinical Dementia Rating Sum of Boxes (P=0.002), Functional Activates Questionnaire (P=0.01), and selective attention (ie, Stroop switching, P=0.009) whereas baseline perfusion from the right middle frontal cortex predicted subsequent episodic memory decline (ie, total recognition discriminability score from the California Verbal Learning Test, P=0.03). These results suggest that hypoperfusion as detected by ASL-MRI can predict subsequent clinical, functional, and cognitive decline and may be useful for identifying candidates for future Alzheimer disease treatment trials.
我们比较了动脉自旋标记磁共振成像(ASL-MRI)测量的脑灌注与 MRI 衍生的海马体积对预测未来认知和功能下降以及随后从轻度认知障碍向痴呆转化的价值。48 名轻度认知障碍患者在基线时接受了结构和 ASL-MRI 扫描,并每年进行临床和神经心理学评估。在纵向观察期间(2.7+/-1.0 年),有 13 名患者发展为痴呆。Cox 回归分析表明,基线海马体积[相对风险(RR)=0.99,P=0.004]、基线右侧下顶叶(RR=0.64,P=0.01)和右侧中额叶(RR=0.73,P=0.01)灌注与向痴呆转化有关。线性混合效应模型的结果表明,右侧楔前叶的基线灌注预测了随后的临床痴呆评定总分(P=0.002)、功能激活问卷(P=0.01)和选择性注意(即斯特鲁普转换,P=0.009)的下降,而右侧中额叶皮层的基线灌注预测了随后的情景记忆下降(即加利福尼亚语言学习测验的总识别辨别力评分,P=0.03)。这些结果表明,ASL-MRI 检测到的灌注不足可以预测随后的临床、功能和认知下降,可能有助于识别未来阿尔茨海默病治疗试验的候选者。